Navigation Links
Prestigious International Champalimaud Vision Award to US Scientists
Date:6/13/2010

NEW YORK, June 11 /PRNewswire/ -- The Champalimaud Foundation, one of the world's largest international scientific institutions, announced today that Dr. J. Anthony Movshon, Director of New York University's Center for Neural Studies, and Dr. William T. Newsome, Investigator at The Howard Hughes Medical Institute and Professor of Neurobiology at Stanford University, are the recipients of its 2010 Vision Award.  The prestigious Champalimaud Vision Award, often called the "Nobel Prize for Vision", comes with a $1.3 million prize, the largest monetary prize in the filed of vision and one of the largest scientific and humanitarian prizes in the world.

This year's Vision Award recognizes the work of both Dr. Movshon and Dr. Newsome over the last 30 years.  Working at times together and at other times separately, these outstanding researchers have had a major impact on scientists' understanding of how the brain reconstructs images, so that human beings can perceive, interpret and act in the world.  By building a bridge between psychophysics and human behavior on the one hand and the physiology of individual neurons and what they compute on the other, these two neuroscientists have shed ground-breaking light upon how the brain reconstructs visual images.

Leonor Beleza, President of The Champalimaud Foundation, said, "Visual perception starts with the eyes, but it happens in the brain.  Over a 30 year period, the work of Dr. Movshon and Dr. Newsome has taken this axiom to new scientific levels of understanding.  Because of these two outstanding neuroscientists, we now have a fundamental appreciation for the role of neurons in how we see things move about in the world.  Their ground-breaking work, taken together and individually, has laid the basis for continued research on how the brain and its processes impact vision and perception.  We are very proud to recognize Drs. Movshon and Newsome as the recipients of the 2010 Champalimaud Vision Award."

In his early studies, Dr. Movshon contributed to the understanding of how the brain represents the form and motion of objects, identifying for the first time neural circuits computing motion perception in the brain's middle temporal lobe (MT).  In a joint 1989 study, that is today considered a classic, Drs. Movshon and Newsome demonstrated that neurons in the MT visual area are responsible for perceptual judgments about direction.  By monitoring neuron responses, they could accurately predict decisions about perception, thus linking perception to specific activity within a neural circuit.  Dr. Newsome demonstrated that by altering the activity of neurons, perceptual performance could be either improved or diminished.

These studies proved that the activity of neurons in the brain's MT is necessary in order for human beings to see moving objects in the world.  By unequivocally demonstrating this fact, Drs. Movshon and Newsome paved the way for studies of the mental processes that link perception to action and for a greater understanding of the complex computations that underlie human decision-making and behavior.

The Champalimaud Vision Award

Established by The Champalimaud Foundation in 2006 and referred to as "the Nobel Prize for Vision" by the former President of India, APJ Kalam, the Vision Award has the support of the World Health Organization's (WHO) "VISION 2020:  The Right to Sight Initiative".  In order to provide maximum support for the fight against blindness, the Award concentrates both on practical blindness prevention and on scientific research.  In odd number years, The Vision Award is given for blindness prevention on the ground, particularly in developing countries.  In even numbered years, the Award recognizes outstanding scientific research.  

In 2007, The Vision Award was presented to India's Aravind Eye Care System; in 2008, it was jointly awarded to Drs. King-Wai Yau and Dr. Jeremy Nathans of Johns Hopkins University; and in 2009, Helen Keller International was the recipient.  The Award is given to recipients for outstanding achievement, and the funds are to be used in any way that furthers and amplifies the recipients' scientific efforts.  

The Jury Panel for The Vision Award is comprised of leading international scientists, including two Nobel Laureates, and prominent public figures.  The are: Alfred Sommer (Johns Hopkins University), Mark Bear (MIT), Nobel Laureate Susumu Tonegawa (MIT), Carla Shatz (Stanford University), Joshua Sanes (Harvard University), Paul A. Sieving (NIH), Gullapalli N. Rao (LV Prasad Eye Institute and International Center for Eyecare Education), Nobel Laureate Amartya Sen (Harvard University), Jose Cuhna-Vaz (Coimbra University), Jacques Delors (former President, European Commission), Antonio Guterres (former Prime Minister of Portugal).

The Champalimaud Foundation

The Champalimaud Foundation is a private organization dedicated to the advancement of biomedical science.  With an endowment of euro 500,000,000, the Foundation's work is focused on three core areas: neuroscience research, cancer research, and an outreach program to support the fight against blindness.  Based in Lisbon, Portugal, the Foundation's new research center (Champalimaud Center for the Unknown) is currently under construction and expected to open in Q4 2010.


'/>"/>
SOURCE The Champalimaud Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders
2. Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders
3. Virtual lab wins prestigious prize awarded by Science
4. Dr. Chang-Hwan Choi honored with prestigious Young Investigator Award
5. DNA Genotek's Oragene•DNA Product Wins Prestigious Medical Design Excellence Award
6. 3 Tufts engineering faculty earn prestigious national awards for promising research
7. Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009
8. Brown engineering professor wins prestigious White House award
9. OpenQ is Awarded Prestigious Life Sciences Industry Award
10. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
11. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... 8, 2016 Should antibiotic bone cement products ... to prevent infection after standard total hip or knee ... ECRI Institute have been fielding a lot lately. ... Bottom Line?" --> "Antibiotic Bone ... --> While there isn,t a simple ...
(Date:2/8/2016)... 2016 --> ... innovation-driven oncology company developing next generation cancer therapeutics ... announced that chairman emeritus of Tata Sons Limited, ... company as part of the first close of ... Navam Capital and Aarin Capital. http://photos.prnewswire.com/prnh/20150923/766442 ...
(Date:2/8/2016)... ... February 08, 2016 , ... Thomas J. Todorow has joined ... President for Corporate Services and the Chief Financial Officer at The Children’s Hospital ... Treasury, Managed Care Contracting, Supply Chain, and Investments. , Prior to joining CHOP ...
Breaking Biology Technology:
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
(Date:1/13/2016)... --> --> ... report titled - Biometric Sensors Market - Global Industry Analysis, ... to the report, the global biometric sensors market was valued at ... US$1,625.8 mn by 2023, expanding at a CAGR of ... the biometric sensors market is expected to reach 1,799.6 ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):